Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) EBT: 2009-2011

Historic EBT for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to -$116.2 million.

  • Lexicon Pharmaceuticals' EBT fell 47.16% to -$33.8 million in Q4 2011 from the same period last year, while for Dec 2011 it was -$115.1 million, marking a year-over-year decrease of 16.03%. This contributed to the annual value of -$116.2 million for FY2011, which is 14.16% down from last year.
  • Per Lexicon Pharmaceuticals' latest filing, its EBT stood at -$116.2 million for FY2011, which was down 14.16% from -$101.8 million recorded in FY2010.
  • In the past 5 years, Lexicon Pharmaceuticals' EBT registered a high of -$93.4 million during FY2009, and its lowest value of -$116.2 million during FY2011.
  • For the 3-year period, Lexicon Pharmaceuticals' EBT averaged around -$103.8 million, with its median value being -$101.8 million (2010).
  • Data for Lexicon Pharmaceuticals' EBT shows a maximum YoY declined of 14.16% (in 2011) over the last 5 years.
  • Yearly analysis of 3 years shows Lexicon Pharmaceuticals' EBT stood at -$93.4 million in 2009, then fell by 8.97% to -$101.8 million in 2010, then fell by 14.16% to -$116.2 million in 2011.